Adrenocortical carcinoma epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Adrenocortical carcinoma}} | {{Adrenocortical carcinoma}} | ||
{{CMG}}; {{AE}} {{RT}} | {{CMG}}; {{AE}} {{RT}} | ||
Revision as of 15:28, 18 September 2012
|
Adrenocortical carcinoma Microchapters |
|
Differentiating Adrenocortical carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Study |
|
Adrenocortical carcinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Adrenocortical carcinoma epidemiology and demographics |
|
FDA on Adrenocortical carcinoma epidemiology and demographics |
|
CDC on Adrenocortical carcinoma epidemiology and demographics |
|
Adrenocortical carcinoma epidemiology and demographics in the news |
|
Blogs on Adrenocortical carcinoma epidemiology and demographics |
|
Risk calculators and risk factors for Adrenocortical carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Raviteja Guddeti, M.B.B.S. [2]
Overview
Adrenocortical carcinoma is a rare tumor, with incidence of 1-2 per million population annually.[1][2] Adrenocortical carcinoma has a bimodal distribution by age, with cases clustering in children under 6, and in adults 30-40 years old.[1]
References
- ↑ 1.0 1.1 edited by Vincent T. DeVita, Samuel Hellman, Steven A. Rosenberg (2005). Cancer: principles & practice of oncology. Philadelphia: Lippincott-Raven. ISBN 0-7817-4865-8.
- ↑ Savarese, Diane MF (August 8, 2006). "Clinical presentation and evaluation of adrenocortical tumors". UpToDate Online v. 15.1. UpToDate. Retrieved June 5, 2007. Unknown parameter
|coauthors=ignored (help)